Stocks and Investing Stocks and Investing
Fri, February 19, 2021
[ 12:00 AM ] - WOPRAI
Jeffrey Goldstein Maintained (WM) at Hold with Decreased Target to $121 on, Feb 19th, 2021
[ 12:00 AM ] - WOPRAI
Kevin Chiang Maintained (WM) at Hold with Decreased Target to $131 on, Feb 19th, 2021
[ 12:00 AM ] - WOPRAI
Michael Hoffman Maintained (WM) at Strong Buy with Increased Target to $149 on, Feb 19th, 2021
[ 12:00 AM ] - WOPRAI
Chris Merwin Maintained (WK) at Hold with Increased Target to $101 on, Feb 19th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Laws Maintained (ACRE) at Buy with Increased Target to $15 on, Feb 19th, 2021
Thu, February 18, 2021
[ 12:00 AM ] - WOPRAI
Chris Caso Maintained (ADI) at Buy with Increased Target to $185 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Harsh Kumar Maintained (ADI) at Buy with Increased Target to $180 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEP) at Buy with Decreased Target to $98 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEE) at Hold with Decreased Target to $78 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Vivek Juneja Upgraded (WFC) to Hold and Increased Target to $37 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Erika Najarian Maintained (WFC) at Hold with Increased Target to $39 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Nicholas Jones Maintained (WIX) at Strong Buy with Increased Target to $360 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Ygal Arounian Maintained (WIX) at Buy with Increased Target to $360 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Maintained (WK) at Hold with Increased Target to $110 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Charles Maintained (WING) at Buy with Decreased Target to $155 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
David Lebovitz Maintained (BPMC) at Hold with Decreased Target to $105 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Peter Lawson Maintained (BPMC) at Hold with Increased Target to $95 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Adam Jonas Maintained (BWA) at Sell with Increased Target to $29 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (ATO) at Buy with Decreased Target to $108 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Richard Hill Maintained (AVB) at Hold with Increased Target to $186 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
David Bishop Initiated (AUB) at Strong Buy and Held Target at $41 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Yaron Werber Maintained (ARGX) at Buy with Increased Target to $430 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Quinn Bolton Maintained (UCTT) at Strong Buy with Increased Target to $55 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Richard Hill Maintained (UDR) at Buy with Increased Target to $47 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Eric Larson Downgraded (ANDE) to Hold on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Michael Lavery Downgraded (TLRY) to Hold and Increased Target to $26 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Mike Hickey Downgraded (TLRY) to Hold on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (XEL) at Sell with Decreased Target to $59 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Patrick Donnelly Maintained (TXG) at Strong Buy with Increased Target to $240 on, Feb 18th, 2021
[ 12:00 AM ] - WOPRAI
Tycho Peterson Maintained (TXG) at Buy with Increased Target to $195 on, Feb 18th, 2021

Tycho Peterson Maintained (TXG) at Buy with Increased Target to $195 on, Feb 18th, 2021


Published on 2024-10-27 15:40:43 - WOPRAI, Tycho Peterson
  Print publication without navigation


Tycho Peterson of JP Morgan, Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $160 to $195 on, Feb 18th, 2021.

Tycho has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Tycho's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $150 on, Wednesday, December 2nd, 2020


This is the rating of the analyst that currently disagrees with Tycho

  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $145 on, Wednesday, November 11th, 2020
Contributing Sources